I can't draw any direct line between lobbying expenditures and NCD actions. But we do know that in the past ten years, there have been only two companies in the whole country who have achieved Parallel Review status. These are Exact Sciences (NCD October 2014) and Foundation Medicine (NCD March 2018). From 2012-2019, Exact invested $1.9M in lobbying. Over a shorter period, from 2015-2019, Foundation Medicine invested $1.2M in lobbying (and you can add $330K in new investments in 1H2020 alone).
Screen shot from Open Secrets below.
|click to enlarge|